| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/16/2004 | US20040180059 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject |
| 09/16/2004 | US20040180058 Vaccine compositions and methods |
| 09/16/2004 | US20040180053 Binding protein |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180050 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
| 09/16/2004 | US20040180048 Administering to a subject in need thereof an effective amount of an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker (NM) protein |
| 09/16/2004 | US20040180046 Bispecific molecules and uses thereof |
| 09/16/2004 | US20040180041 Administering to or transplanting into patient at least one cell or tissue obtained from a cloned ungulate animal or embryo |
| 09/16/2004 | US20040180040 Methods and compositions for directing cells to target organs |
| 09/16/2004 | US20040180038 Effectors of innate immunity determination |
| 09/16/2004 | US20040180037 Use of IL-7 for treating autoimmune diseases, in particular insulin-dependent diabetes mellitus |
| 09/16/2004 | US20040180036 Salts of codrugs and uses related thereto |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | US20040180033 Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
| 09/16/2004 | US20040180027 Use of repeat sequence protein polymers in personal care compositions |
| 09/16/2004 | US20040180026 Topical skin care composition |
| 09/16/2004 | DE10327066A1 Bestimmung agonistischer Autoantikörper Determination of agonistic autoantibodies |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2768008A1 Clostridial neurotoxins for treating uterine disorders |
| 09/16/2004 | CA2518268A1 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 09/16/2004 | CA2518187A1 Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
| 09/16/2004 | CA2518157A1 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| 09/16/2004 | CA2518155A1 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 09/16/2004 | CA2518150A1 Methods and compositions involving mda-7 |
| 09/16/2004 | CA2518148A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/16/2004 | CA2518143A1 Delivery system for drug and cell therapy |
| 09/16/2004 | CA2518136A1 Oral insulin composition and methods of making and using thereof |
| 09/16/2004 | CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | CA2518020A1 Alpha-keto carbonyl calpain inhibitors |
| 09/16/2004 | CA2517959A1 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
| 09/16/2004 | CA2517953A1 Novel gene relating to fibrotic conditions |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/16/2004 | CA2517899A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2517896A1 Use of thyroid-stimulating hormone to induce lipolysis |
| 09/16/2004 | CA2517767A1 Ligands that bind to the amyloid-.beta. precursor peptide and related molecules and uses thereof |
| 09/16/2004 | CA2517158A1 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2516776A1 Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
| 09/16/2004 | CA2516677A1 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | CA2516098A1 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | CA2514730A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 09/15/2004 | EP1457558A1 WEED CONTROLLER METABOLISM PROTEINS, GENES THEREOF AND USE OF THE SAME |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457498A1 Novel peptide having angiotensin convertase inhibitory effect |
| 09/15/2004 | EP1457497A1 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/15/2004 | EP1457210A1 Remedies and/or preventives for conformational diseases |
| 09/15/2004 | EP1456665A2 Breast cancer associated polypeptide |
| 09/15/2004 | EP1456656A2 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456652A2 Agents that modulate immune cell activation and methods of use thereof |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456396A1 Hybrid glycosylated products and their production and use |
| 09/15/2004 | EP1456387A2 Expression vector for the production of annexin v |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456380A2 Smad7 inhibitors for the treatment of cns diseases |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456236A2 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases |
| 09/15/2004 | EP1456235A2 Factor viii c2 domain variants |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456231A2 Streptococcus antigens |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456229A2 Method for preparing echinocandin derivatives |
| 09/15/2004 | EP1456223A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1455858A2 Catheter composition and uses thereof |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455831A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455826A2 Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment of multiple sclerosis |
| 09/15/2004 | EP1455814A2 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof |
| 09/15/2004 | EP1455813A2 Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease |
| 09/15/2004 | EP1455812A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455809A2 Inhibitors of hepatitis c virus |
| 09/15/2004 | EP1455808A1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 09/15/2004 | EP1455807A2 METHOD FOR USE OF IGF-BINDING PROTEIN FOR SELECTIVE SENSITIZATION OF TARGET CELLS i IN VIVO /i |
| 09/15/2004 | EP1455778A2 Methods for the treatment of peripheral neural and vascular ailments |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455766A2 Thymosin alpha 1 peptide/polymer conjugates |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455753A1 Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant |
| 09/15/2004 | EP1455588A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1351709B1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1282425A4 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 09/15/2004 | EP1257576B1 Vasoactive intestinal peptide analogs |
| 09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
| 09/15/2004 | EP1229890B1 Dyeing composition promoting natural pigmentation, method for obtaining same and use for colouring the skin and/or keratinous fibres |
| 09/15/2004 | EP1206271B1 Composition and method for enhancing wound healing |